Sprout Health NAD+ review

The NAD card is worth separating from the weight-care offer

Sprout Health places compounded NAD+ inside a broader telehealth service, with a starting figure of $199. The NAD card describes a prescription-only preparation and clinician assessment. ^[1] That earns it a place in a service comparison, although the offer is less complete than the prominent weight-care pricing on the same homepage.

I would approach Sprout as a consultation-and-fulfillment option rather than a ready-made answer to tiredness. Its strongest practical feature is an identifiable clinical pathway. The missing pieces are the actual NAD preparation, how much the quote supplies and the period that payment covers. Until those are attached, a starting price has limited value for deciding whether Sprout is economical.

The ingredient is named; the prescription still needs detail

The site identifies nicotinamide adenine dinucleotide and says a licensed third-party pharmacy compounds and dispenses it. Sprout states that it is not the pharmacy or manufacturer. ^[1] This helps identify the parties involved, but does not tell a prospective patient which pharmacy will supply their particular prescription.

Ask for the actual concentration, supplied amount, administration route and pharmacy instructions once the clinician recommends a plan. Those details distinguish an injectable prescription from an oral precursor bottle or a clinic infusion. A photograph of a vial should not substitute for the label that arrives. It also should not be used to infer a dose or schedule that the treating clinician has not selected.

Read our NAD delivery-format guide for the next part of the decision.

A starting price is not a duration

The $199 figure is presented as a starting price without a clear NAD billing interval on that card. ^[1] I would leave the monthly comparison open until Sprout supplies the selected plan in writing. The semaglutide and tirzepatide figures elsewhere describe different medicines and cannot fill that gap.

This matters because identical-looking starting charges can buy different quantities or periods. Compare the first charge, recurring charge and shipment contents together. If a longer commitment lowers a monthly equivalent, identify the amount due today as well. A useful quote makes it possible to stop guessing about how long a vial lasts, what a refill costs and whether a consultation creates a separate obligation.

The clinical pitch needs a narrower evidence standard

Sprout explicitly says compounded NAD+ is not FDA-approved. ^[1] Its placement under energy and longevity does not establish those outcomes. The published human infusion pilot measured metabolism around a small, six-hour experiment; it was not a demonstration that home NAD prescriptions reverse aging or resolve nonspecific fatigue. ^[2]

For this purchase, ask what specific problem the clinician proposes to address and which evidence applies to the actual preparation. A biological explanation can make a discussion interesting while leaving personal benefit uncertain. I would not pay a premium simply because an intervention sounds more direct than an oral supplement. The decision needs a clear purpose, not just a more elaborate delivery method.

Read our human infusion evidence review for the next part of the decision.

Support should connect the right people

Sprout publishes a patient-care contact and describes online review with prescription fulfillment when clinically appropriate. ^[1] A visible support route is helpful. Before subscribing, establish whether a medication concern reaches the clinical team directly and which questions belong with the dispensing pharmacy.

That division becomes practical when packaging is unclear, a shipment arrives late or the reader wants to discuss a symptom. Customer service can help with an order, while a prescribing decision needs an appropriate clinician. I would also confirm the instructions for a delayed or compromised delivery. Convenience is strongest when the follow-up route is as understandable as the intake, rather than ending once the first order is paid.

My shortlist decision

Sprout says plans renew automatically and that billing frequency and cancellation details appear before checkout. ^[1] Save those selected terms alongside the prescription quote. The attractive part of the service is access to an online clinical review and licensed-pharmacy fulfillment. The limitation is that the public NAD card does not support a complete recurring budget.

I would keep Sprout on a preliminary shortlist if the reader already has a reason to discuss NAD with a clinician. I would move it onto a final shortlist only after the quote names the medicine, quantity, interval and included follow-up. Someone seeking certainty about energy or longevity should not treat this service as that certainty. The offer is a way to arrange care; the benefit question still needs a careful, individual conversation.

Read our CoreAge versus AgelessRx comparison for the next part of the decision.

Understanding the cost

The NAD+ listing starts at $199. Confirm the quantity, supply period, renewal charge and full selected-plan total. GLP-1 prices do not apply. ^[1]